Evidence map›Paper›PMID 22116590›Full record

ArticleThe international journal of cardiovascular imaging2012

Acipimox-enhanced ¹⁸F-fluorodeoxyglucose positron emission tomography for characterizing and predicting early remodeling in the rat infarct model.

Mélanie Bousquenaud, Fatiha Maskali, Sylvain Poussier, Pierre-Yves Marie, Henri Boutley, Gilles Karcher, Daniel R Wagner, Yvan Devaux

Abstract read
PubMed Publisher
In one paragraph

Article in The international journal of cardiovascular imaging, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Positron emission tomography in the assessment of left ventricular function in healthy rats: a comparison of four imaging methods.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2013
    Article
  5. Cardiovascular imaging 2012 in the International Journal of Cardiovascular Imaging.The international journal of cardiovascular imaging · 2013
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mélanie BousquenaudLaboratory of Cardiovascular Research Centre de Recherche Public-Santé, Luxembourg, Luxembourg.
Fatiha Maskali
Sylvain Poussier
Pierre-Yves Marie
Henri Boutley
Gilles Karcher
Daniel R Wagner
Yvan Devaux

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rat myocardial infarction (MI) model is widely used to study left ventricular (LV) remodeling. In this study, acipimox-enhanced (18)F-Fluorodeoxyglucose (FDG) gated-positron emission tomography (PET) was assessed for characterizing and predicting early remodeling in the rat infarct model. Nineteen Wistar rats had surgical occlusion of the left anterior descending coronary artery and 7 were sham-operated. PET was scheduled 48 h and 2 weeks later for quantifying MI area and LV function. Segments with <50% of FDG uptake had histological evidence of MI (74 ± 9% decrease in parietal thickness, fibrosis development). At 48 h, MI area was large (>35% of LV) in 6 rats, moderate (15-35% of LV) in 8 rats, limited (<15% of LV) in 5 rats and absent in the 7 sham rats. LV remodeling, assessed through the 2 weeks increase in end-diastolic volume, increased between rats with limited, moderate and large MI (+72 ± 25, +109 ± 56, +190 ± 69 μl, respectively, P = 0.007). This 3-groups classification allowed predicting 44% of the 2 weeks increase in end-diastolic volume, and additional 34% were predicted by heart rate at 48 h. The acipimox-enhanced FDG gated-PET technique provides efficient characterization and prediction of early remodeling in the rat infarct model.

Indexed as

Fluorodeoxyglucose F18Hypolipidemic AgentsPositron-Emission TomographyPyrazinesRadiopharmaceuticalsVentricular RemodelingAnimalsDiastoleDisease Models, AnimalMaleMyocardial InfarctionMyocardiumPredictive Value of TestsRatsRats, WistarTime FactorsacipimoxFluorodeoxyglucose F18Hypolipidemic AgentsPyrazinesRadiopharmaceuticals

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.